Filed: 2/12/2026ACC: 0002104501-26-000004
📋 What this filing means
REMEDIUM CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $170.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$170.2K
Total AUM (reported)
5.65M
Total Shares
Allocation by class
COM$170.2K100.0%
Portfolio Concentration
Top 3$138.8K81.6%
4–10$31.4K18.4%
Top 3 weight
81.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.65M
Sole
Full voting authority
5.65M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Spyre Therapeutics Inc
SOLEShares1.46M
TypeSH
Market value$47.7K
28.03%
Sole
1.46M
Shared
0.00
None
0.00
Oruka Therapeutics Inc
SOLEShares1.55M
TypeSH
Market value$47.1K
27.64%
Sole
1.55M
Shared
0.00
None
0.00
Apogee Therapeutics Inc
SOLEShares583.59K
TypeSH
Market value$44.0K
25.88%
Sole
583.59K
Shared
0.00
None
0.00
Jade Biosciences Inc
SOLEShares1.58M
TypeSH
Market value$24.3K
14.30%
Sole
1.58M
Shared
0.00
None
0.00
Crescent Biopharma Inc
SOLEShares361.25K
TypeSH
Market value$4.3K
2.52%
Sole
361.25K
Shared
0.00
None
0.00
Galecto Inc
SOLEShares120.47K
TypeSH
Market value$2.8K
1.63%
Sole
120.47K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Spyre Therapeutics IncSOLE | COM | 1.46M | SH | $47.7K 28.03% | 1.46M | 0.00 | 0.00 |
Oruka Therapeutics IncSOLE | COM | 1.55M | SH | $47.1K 27.64% | 1.55M | 0.00 | 0.00 |
Apogee Therapeutics IncSOLE | COM | 583.59K | SH | $44.0K 25.88% | 583.59K | 0.00 | 0.00 |
Jade Biosciences IncSOLE | COM | 1.58M | SH | $24.3K 14.30% | 1.58M | 0.00 | 0.00 |
Crescent Biopharma IncSOLE | COM | 361.25K | SH | $4.3K 2.52% | 361.25K | 0.00 | 0.00 |
Galecto IncSOLE | COM | 120.47K | SH | $2.8K 1.63% | 120.47K | 0.00 | 0.00 |